Cargando…
Barberry Administration and Pro-Oxidant–Antioxidant Balance in Patients With Metabolic Syndrome
BACKGROUND: Metabolic syndrome is the constellation of several cardiometabolic risk factors, and is associated with a heightened risk of coronary heart disease (CHD). The pro-oxidant–antioxidant balance (PAB) is a measure of factors that promote and control oxidative stress. PAB may also be associat...
Autores principales: | Mohammadi, Akram, Sahebkar, Amirhossein, Kermani, Tayyebeh, Zhilaee, Marzieh, Tavallaie, Shima, Ghayour Mobarhan, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341350/ https://www.ncbi.nlm.nih.gov/pubmed/25763235 http://dx.doi.org/10.5812/ircmj.16786 |
Ejemplares similares
-
Saffron supplements modulate serum pro-oxidant-antioxidant balance in patients with metabolic syndrome: A randomized, placebo-controlled clinical trial
por: Kermani, Tayyebeh, et al.
Publicado: (2015) -
Serum pro-oxidant/antioxidant balance in term versus preterm neonates
por: Boskabadi, Hassan, et al.
Publicado: (2022) -
Barberry in the treatment of obesity and metabolic syndrome: possible mechanisms of action
por: Firouzi, Safieh, et al.
Publicado: (2018) -
Investigation of Serum Oxidized Low-Density Lipoprotein IgG Levels in Patients with Angiographically Defined Coronary Artery Disease
por: Moohebati, Mohsen, et al.
Publicado: (2014) -
Pro-oxidant antioxidant balance in patients with non-alcoholic fatty liver disease
por: Nobakht Motlagh Ghoochani, Bibi Fatemeh, et al.
Publicado: (2019)